Aclaris Therapeutics, Inc. SEC filings ACRS
Aclaris Therapeutics, Inc. has 872 filings in SEC EDGAR's recent list, going back to Sep 10, 2012. Its latest annual report, Form ARS, was filed on Apr 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Results of operations
|
Nov 5, 2026 | Nov 5, 2026 |
| 8-K |
Current report
Material agreement
|
Oct 27, 2026 | Oct 27, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure, Other events
|
Oct 27, 2026 | Oct 27, 2026 |
| 8-K |
Current report
Material agreement
|
Aug 6, 2026 | Aug 6, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2026 | Aug 6, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 4, 2026 | Jun 4, 2026 |
| 8-K |
Current report
Results of operations
|
May 7, 2026 | May 7, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Apr 28, 2026 | Apr 28, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 11, 2026 | Mar 10, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 10, 2026 | Mar 9, 2026 |
| 8-K |
Current report
Results of operations
|
Feb 26, 2026 | Feb 26, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 12, 2026 | Jan 12, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jan 6, 2026 | Jan 6, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2025 | Nov 6, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 14, 2025 | Oct 14, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2025 | Aug 7, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jul 29, 2025 | Jul 29, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 30, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results
|
Jun 5, 2025 | Jun 5, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 8, 2025 | May 8, 2025 |
| 8-K |
Current report
Results of operations
|
Feb 27, 2025 | Feb 27, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 13, 2025 | Jan 13, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Officer or director change, Regulation FD disclosure, Other events
|
Nov 18, 2024 | Nov 16, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2024 | Nov 6, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2024 | Aug 7, 2024 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jul 16, 2024 | Jul 16, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 7, 2024 | Jun 6, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 7, 2024 | May 7, 2024 |
| 8-K |
Current report
Officer or director change
|
Mar 19, 2024 | Mar 14, 2024 |
| 8-K |
Current report
Results of operations
|
Feb 27, 2024 | Feb 27, 2024 |
| 8-K/A |
Amended current report
Officer or director change
|
Feb 5, 2024 | Jan 15, 2024 |
| 8-K |
Current report
Officer or director change
|
Feb 5, 2024 | Jan 31, 2024 |
| 8-K |
Current report
Results of operations, Officer or director change
|
Jan 19, 2024 | Jan 15, 2024 |
| 8-K |
Current report
Exit or restructuring costs, Regulation FD disclosure
|
Dec 19, 2023 | Dec 19, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Nov 13, 2023 | Nov 13, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2023 | Nov 6, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 18, 2023 | Sep 18, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2023 | Aug 7, 2023 |
| 8-K |
Current report
Officer or director change
|
Jun 12, 2023 | Jun 9, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jun 2, 2023 | Jun 1, 2023 |
| 8-K |
Current report
Material agreement
|
Jun 1, 2023 | May 26, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 8, 2023 | May 8, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 14, 2023 | Apr 14, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 31, 2023 | Mar 30, 2023 |
| 8-K |
Current report
Officer or director change
|
Mar 27, 2023 | Mar 23, 2023 |
| 8-K |
Current report
Other events
|
Mar 6, 2023 | Mar 6, 2023 |
| 8-K |
Current report
Material agreement, Agreement ended
|
Feb 23, 2023 | Feb 23, 2023 |
| 8-K |
Current report
Results of operations
|
Feb 23, 2023 | Feb 23, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 9, 2023 | Jan 9, 2023 |
| 8-K |
Current report
Officer or director change
|
Jan 6, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Officer or director change
|
Dec 13, 2022 | Dec 9, 2022 |
| 8-K |
Current report
Officer or director change
|
Nov 22, 2022 | Nov 18, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 8, 2022 | Nov 8, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 3, 2022 | Aug 3, 2022 |
| 8-K |
Current report
Officer or director change
|
Aug 1, 2022 | Aug 1, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 3, 2022 | Jun 2, 2022 |
| 8-K |
Current report
Results of operations
|
May 10, 2022 | May 10, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 14, 2022 | Apr 13, 2022 |
| 8-K |
Current report
Results of operations
|
Feb 24, 2022 | Feb 24, 2022 |
| 8-K |
Current report
Officer or director change
|
Jan 14, 2022 | Jan 12, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 7, 2021 | Dec 7, 2021 |
| 8-K |
Current report
Results of operations, Officer or director change
|
Nov 2, 2021 | Nov 1, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 27, 2021 | Aug 27, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2021 | Aug 5, 2021 |
| 8-K |
Current report
Agreement ended
|
Jul 26, 2021 | Jul 23, 2021 |
| 8-K |
Current report
Material agreement, Other events
|
Jun 11, 2021 | Jun 8, 2021 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 8, 2021 | Jun 8, 2021 |
| 8-K |
Current report
Shareholder vote results
|
Jun 3, 2021 | Jun 3, 2021 |
| 8-K |
Current report
Material agreement
|
May 20, 2021 | May 20, 2021 |
| 8-K |
Current report
Results of operations
|
May 7, 2021 | May 7, 2021 |
| 8-K |
Current report
Results of operations
|
Feb 25, 2021 | Feb 25, 2021 |
| 8-K |
Current report
Material agreement, Agreement ended, Other events
|
Jan 22, 2021 | Jan 19, 2021 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jan 19, 2021 | Jan 19, 2021 |
| 8-K |
Current report
Other events
|
Dec 15, 2020 | Dec 15, 2020 |
| 8-K |
Current report
Results of operations
|
Nov 4, 2020 | Nov 4, 2020 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 15, 2020 | Sep 15, 2020 |
| 8-K |
Current report
Officer or director change
|
Aug 14, 2020 | Aug 13, 2020 |
| 8-K |
Current report
Material agreement
|
Aug 13, 2020 | Aug 13, 2020 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2020 | Aug 7, 2020 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Jun 24, 2020 | Jun 23, 2020 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 17, 2020 | Jun 17, 2020 |
| 8-K |
Current report
Shareholder vote results
|
Jun 4, 2020 | Jun 4, 2020 |
| 8-K |
Current report
Regulation FD disclosure
|
May 27, 2020 | May 27, 2020 |
| 8-K |
Current report
Regulation FD disclosure
|
May 15, 2020 | May 15, 2020 |
| 8-K |
Current report
Results of operations
|
May 7, 2020 | May 7, 2020 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale, Regulation FD disclosure
|
Mar 31, 2020 | Mar 30, 2020 |
| 8-K |
Current report
Material agreement
|
Mar 13, 2020 | Mar 13, 2020 |
| 8-K |
Current report
Results of operations
|
Feb 25, 2020 | Feb 25, 2020 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 13, 2020 | Jan 13, 2020 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jan 8, 2020 | Jan 7, 2020 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 3, 2019 | Dec 2, 2019 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 21, 2019 | Nov 21, 2019 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2019 | Nov 7, 2019 |
| 8-K |
Current report
Material agreement
|
Oct 17, 2019 | Oct 15, 2019 |
| 8-K |
Current report
Material agreement, Agreement ended, Acquisition or sale of assets, Regulation FD disclosure
|
Oct 11, 2019 | Oct 10, 2019 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 27, 2019 | Sep 27, 2019 |
| 8-K |
Current report
Officer or director change
|
Sep 9, 2019 | Sep 3, 2019 |
| 8-K |
Current report
Exit or restructuring costs, Regulation FD disclosure
|
Sep 5, 2019 | Sep 3, 2019 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2019 | Aug 8, 2019 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 30, 2019 | Jul 30, 2019 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jul 3, 2019 | Jul 2, 2019 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 17, 2019 | Jun 17, 2019 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 7, 2019 | Jun 6, 2019 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 5, 2019 | Jun 5, 2019 |
| 8-K |
Current report
Results of operations
|
May 8, 2019 | May 8, 2019 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 4, 2019 | Apr 4, 2019 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 18, 2019 | Mar 18, 2019 |
| 8-K |
Current report
Other events
|
Feb 8, 2019 | Feb 8, 2019 |
| 8-K/A | Amended current report | Jan 18, 2019 | Nov 30, 2018 |
| 8-K |
Current report
Officer or director change
|
Dec 20, 2018 | Dec 17, 2018 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 17, 2018 | Dec 17, 2018 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Regulation FD disclosure
|
Dec 3, 2018 | Nov 30, 2018 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2018 | Nov 6, 2018 |
| 8-K |
Current report
New debt
|
Oct 31, 2018 | Oct 31, 2018 |
| 8-K |
Current report
Material agreement, Other events
|
Oct 18, 2018 | Oct 17, 2018 |
| 8-K |
Current report
Material agreement, Results of operations, New debt
|
Oct 15, 2018 | Oct 15, 2018 |
| 8-K |
Current report
Agreement ended
|
Oct 4, 2018 | Oct 2, 2018 |
| 8-K |
Current report
Results of operations
|
Aug 3, 2018 | Aug 3, 2018 |
| 8-K |
Current report
Shareholder vote results
|
Jun 8, 2018 | Jun 7, 2018 |
| 8-K |
Current report
Results of operations
|
May 8, 2018 | May 8, 2018 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Apr 25, 2018 | Apr 20, 2018 |
| 8-K |
Current report
Results of operations
|
Mar 12, 2018 | Mar 12, 2018 |
| 8-K |
Current report
Material agreement
|
Jan 30, 2018 | Jan 24, 2018 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jan 8, 2018 | Jan 8, 2018 |
| 8-K |
Current report
Other events
|
Dec 15, 2017 | Dec 15, 2017 |
| 8-K |
Current report
Agreement ended
|
Dec 1, 2017 | Nov 30, 2017 |
| 8-K |
Current report
Agreement ended
|
Nov 28, 2017 | Nov 27, 2017 |
| 8-K |
Current report
Listing notice
|
Nov 9, 2017 | Nov 7, 2017 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2017 | Nov 7, 2017 |
| 8-K |
Current report
Material agreement
|
Nov 6, 2017 | Nov 2, 2017 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 4, 2017 | Oct 4, 2017 |
| 8-K |
Current report
Material agreement, Other events
|
Aug 11, 2017 | Aug 9, 2017 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Aug 9, 2017 | Aug 9, 2017 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2017 | Aug 8, 2017 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Regulation FD disclosure
|
Aug 8, 2017 | Aug 3, 2017 |
| 8-K |
Current report
Officer or director change
|
Aug 1, 2017 | Jul 31, 2017 |
| 8-K |
Current report
Shareholder vote results
|
Jun 16, 2017 | Jun 15, 2017 |
| 8-K |
Current report
Results of operations
|
May 9, 2017 | May 9, 2017 |
| 8-K |
Current report
Other events
|
Apr 21, 2017 | Apr 21, 2017 |
| 8-K |
Current report
Results of operations
|
Mar 15, 2017 | Mar 15, 2017 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jan 26, 2017 | Jan 25, 2017 |
| 8-K |
Current report
Material agreement, Other events
|
Nov 18, 2016 | Nov 16, 2016 |
| 8-K |
Current report
Other events
|
Nov 15, 2016 | Nov 15, 2016 |
| 8-K |
Current report
Results of operations
|
Nov 3, 2016 | Nov 3, 2016 |
| 8-K |
Current report
Material agreement
|
Nov 2, 2016 | Nov 2, 2016 |
| 8-K |
Current report
Other events
|
Sep 13, 2016 | Sep 13, 2016 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2016 | Aug 11, 2016 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Aug 4, 2016 | Jul 29, 2016 |
| 8-K |
Current report
Shareholder vote results
|
Jun 29, 2016 | Jun 29, 2016 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Jun 2, 2016 | May 27, 2016 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
May 27, 2016 | May 27, 2016 |
| 8-K |
Current report
Results of operations
|
May 11, 2016 | May 11, 2016 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Regulation FD disclosure
|
Mar 30, 2016 | Mar 24, 2016 |
| 8-K |
Current report
Results of operations
|
Mar 23, 2016 | Mar 23, 2016 |
| 8-K |
Current report
Results of operations
|
Nov 18, 2015 | Nov 18, 2015 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Oct 13, 2015 | Oct 13, 2015 |
Showing 156 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ACRS (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Wayne, PA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1557746
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.